Additionally, acetylated proteins mark disease progression; for example, acetylated tau is a novel pathological signature in Alzheimer's disease,46 and acetylated tau in the blood could be applied clinically to examine patients with traumatic brain injury.11 Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.